Jim Cramer names hot sectors that could use a pullback
CNBC's Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them while they're hot.
health.economictimes.indiatimes6h
Merck KGaA Q3 earnings rise faster than expected on lower costs
above an average analyst estimate of 1.55 billion in a consensus posted on the company's website. Frankfurt: Merck KGaA on ...
The Pharma Letter10h
Merck KGaA shares slip on cautious outlook
a jump of 11.8% and ahead of an average analyst estimate of 1.55 billion euros in a consensus posted on the company’s website ...
manilatimes1d
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
The collaboration with Merck KGaA, Darmstadt, Germany focuses on discovering ... A live webcast of the presentation will be ...
Children’s Inn at NIH breaks ground on project to make room for more families
The Children’s Inn at the National Institutes of Health is breaking ground on a project that will allow the nonprofit to ...
Business Wire2d
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) Statistically significant and clinically ...
manilatimes3d
IO Biotech Announces Participation in Upcoming Investor Conferences
The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to IO102-IO103. IO Biotech is ...
Future Market Insights3d
Middle East Veterinary Vaccine Market to Reach USD 973.8 Million by 2033, Growing at a 4% CAGR
The Middle East Veterinary Vaccine Market is poised for steady growth, with a projected market size of USD 627.1 million in 2023. The market is expected to expand at a CAGR of 4% through 2033, ...